Market revenue in 2023 | USD 11,011.0 million |
Market revenue in 2030 | USD 18,531.7 million |
Growth rate | 7.7% (CAGR from 2023 to 2030) |
Largest segment | Manufacturing |
Fastest growing segment | Research |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Manufacturing, Research |
Key market players worldwide | Catalent Inc, Pharmaceutical Product Development, AbbVie Inc, Baxter International Inc, Grifols SA Ordinary Shares - Class A, Dalton Pharma Services, Boehringer Ingelheim, Lonza Group Ltd |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pharmaceutical contract manufacturing and research services market will help companies and investors design strategic landscapes.
Manufacturing was the largest segment with a revenue share of 65.97% in 2023. Horizon Databook has segmented the Australia pharmaceutical contract manufacturing and research services market based on manufacturing, research covering the revenue growth of each sub-segment from 2018 to 2030.
Australian healthcare is one of the best healthcare systems in the world. The increasing awareness about the need for early detection of lifestyle and chronic diseases is promoting the pharmaceutical market in the country.
Like other governments, the Australian government also initiated schemes to provide medicines at subsidized rates.
For instance, as per Pharmaceutical Benefits Scheme (PBS), medicines are available for all eligible patients at a subsidized cost.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia pharmaceutical contract manufacturing and research services market, including forecasts for subscribers. This country databook contains high-level insights into Australia pharmaceutical contract manufacturing and research services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account